Oura’s going public.
What’s happening: The Finnish smart ring maker confidentially filed IPO paperwork with the SEC as sales, revenue, and healthcare partnerships surge.
Peak Oura. 4x’ing membership and revenue over two years, Oura is projected to eclipse 5M paid members this quarter. Landing an unprecedented $900M at a $11B valuation, it’s picking up the pace, landing in 4.6K retail locations while signing up 1.2K enterprise partners.
Promise ring. Building a loyal following, 80% of Oura users renew subscriptions after the first year — drawn to hyper-personalized health signals across sleep, stress, metabolism, women’s health, and more.
With over half of users managing at least one chronic condition, 80% use ring data to guide treatment. Winning with women, it’s tracked 26M cycles and 350K pregnancies.
Full-stack. Investing gross profit back into its ecosystem, it’s declaring as a “global health intelligence” platform — funding acquisitions across AI and gesture control en route to what CEO Tom Hale envisions as a “cloud of wearables” tying together diagnostic and action layers.
Increasingly leaning medical, it’s helping guide treatment for Maven, Vida Health, and Abu Dhabi’s department of health while piloting features for blood pressure and adding AI-decoded bloodwork.
Looking ahead: Sitting on a mountain of data, Oura is ready to power a preventative health future. Taking momentum into the public market, it’ll set the stage for more to follow.
